Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg

NCT00649181 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Metolazone Tablets 5 mg
DRUG: Zaroloxyn® Tablets 5 mg

Sponsor

Mylan Pharmaceuticals Inc